260 related articles for article (PubMed ID: 30097640)
1. Impact of Body Mass Index on Oncological Outcomes of Prostate Cancer Patients after Radical Prostatectomy.
Yu YD; Byun SS; Lee SE; Hong SK
Sci Rep; 2018 Aug; 8(1):11962. PubMed ID: 30097640
[TBL] [Abstract][Full Text] [Related]
2. Low body mass index is associated with adverse oncological outcomes following radical prostatectomy in Korean prostate cancer patients.
Koo KC; Yoon YE; Rha KH; Chung BH; Yang SC; Hong SJ
Int Urol Nephrol; 2014 Oct; 46(10):1935-40. PubMed ID: 24817520
[TBL] [Abstract][Full Text] [Related]
3. Radical prostatectomy neutralizes obesity-driven risk of prostate cancer progression.
Schiffmann J; Salomon G; Tilki D; Budäus L; Karakiewicz PI; Leyh-Bannurah SR; Pompe RS; Haese A; Heinzer H; Huland H; Graefen M; Tennstedt P
Urol Oncol; 2017 May; 35(5):243-249. PubMed ID: 28161322
[TBL] [Abstract][Full Text] [Related]
4. Obesity is associated with biochemical recurrence after radical prostatectomy: A multi-institutional extended validation study.
Maj-Hes AB; Mathieu R; Özsoy M; Soria F; Moschini M; Abufaraj M; Briganti A; Roupret M; Karakiewicz PI; Klatte T; Shariat SF
Urol Oncol; 2017 Jul; 35(7):460.e1-460.e8. PubMed ID: 28460801
[TBL] [Abstract][Full Text] [Related]
5. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
[TBL] [Abstract][Full Text] [Related]
6. Obesity does not increase the risk of lymph node metastases in patients with clinically localized prostate cancer undergoing radical prostatectomy and extended pelvic lymph node dissection.
Briganti A; Karakiewicz PI; Chun FK; Suardi N; Gallina A; Abdollah F; Freschi M; Doglioni C; Rigatti P; Montorsi F
Int J Urol; 2009 Aug; 16(8):676-81. PubMed ID: 19602006
[TBL] [Abstract][Full Text] [Related]
7. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
[TBL] [Abstract][Full Text] [Related]
8. Obesity and long-term survival after radical prostatectomy.
Chalfin HJ; Lee SB; Jeong BC; Freedland SJ; Alai H; Feng Z; Trock BJ; Partin AW; Humphreys E; Walsh PC; Han M
J Urol; 2014 Oct; 192(4):1100-4. PubMed ID: 24769031
[TBL] [Abstract][Full Text] [Related]
9. Short (≤ 1 mm) positive surgical margin and risk of biochemical recurrence after radical prostatectomy.
Shikanov S; Marchetti P; Desai V; Razmaria A; Antic T; Al-Ahmadie H; Zagaja G; Eggener S; Brendler C; Shalhav A
BJU Int; 2013 Apr; 111(4):559-63. PubMed ID: 22759270
[TBL] [Abstract][Full Text] [Related]
10. Body mass index as a prognostic marker for biochemical recurrence in Dutch men treated with radical prostatectomy.
van Roermund JG; Kok DE; Wildhagen MF; Kiemeney LA; Struik F; Sloot S; van Oort IM; Hulsbergen-van de Kaa CA; van Leenders GJ; Bangma CH; Witjes JA
BJU Int; 2009 Aug; 104(3):321-5. PubMed ID: 19220264
[TBL] [Abstract][Full Text] [Related]
11. Body mass index is associated with higher Gleason score and biochemical recurrence risk following radical prostatectomy in Chinese men: a retrospective cohort study and meta-analysis.
Bai PD; Hu MB; Xu H; Zhu WH; Hu JM; Yang T; Jiang HW; Ding Q
World J Surg Oncol; 2015 Nov; 13():311. PubMed ID: 26542246
[TBL] [Abstract][Full Text] [Related]
12. Obesity and prostate cancer-specific mortality after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
Vidal AC; Howard LE; Sun SX; Cooperberg MR; Kane CJ; Aronson WJ; Terris MK; Amling CL; Freedland SJ
Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):72-78. PubMed ID: 27698439
[TBL] [Abstract][Full Text] [Related]
13. The risk of upstaged disease increases with body mass index in low-risk prostate cancer patients eligible for active surveillance.
Ploussard G; de la Taille A; Bayoud Y; Durand X; Terry S; Xylinas E; Allory Y; Vacherot F; Abbou CC; Salomon L
Eur Urol; 2012 Feb; 61(2):356-62. PubMed ID: 21803484
[TBL] [Abstract][Full Text] [Related]
14. The relationship between body-mass index, physical activity, and pathologic and clinical outcomes after radical prostatectomy for prostate cancer.
Wissing M; Chevalier S; McKercher G; Laprise C; Aprikian S; O'Flaherty A; Scarlata E; Saad F; Carmel M; Lacombe L; Brimo F; Latour M; Ekindi-Ndongo N; Têtu B; Aprikian A
World J Urol; 2019 May; 37(5):789-798. PubMed ID: 30136199
[TBL] [Abstract][Full Text] [Related]
15. Is body mass index associated with pathological outcomes after radical prostatectomy in Korean men?
Lee SE; Lee WK; Jeong MS; Abdullajanov M; Kim DS; Park HZ; Jeong SJ; Yoon CY; Byun SS; Choe G; Hong SK
BJU Int; 2011 Apr; 107(8):1250-5. PubMed ID: 20880194
[TBL] [Abstract][Full Text] [Related]
16. Preoperative Multiparametric Magnetic Resonance Imaging Predicts Biochemical Recurrence in Prostate Cancer after Radical Prostatectomy.
Ho R; Siddiqui MM; George AK; Frye T; Kilchevsky A; Fascelli M; Shakir NA; Chelluri R; Abboud SF; Walton-Diaz A; Sankineni S; Merino MJ; Turkbey B; Choyke PL; Wood BJ; Pinto PA
PLoS One; 2016; 11(6):e0157313. PubMed ID: 27336392
[TBL] [Abstract][Full Text] [Related]
17. Cancer-specific survival and predictors of prostate-specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy.
Secin FP; Bianco FJ; Vickers AJ; Reuter V; Wheeler T; Fearn PA; Eastham JA; Scardino PT
Cancer; 2006 Jun; 106(11):2369-75. PubMed ID: 16649221
[TBL] [Abstract][Full Text] [Related]
18. The impact of body mass index on treatment outcomes for patients with low-intermediate risk prostate cancer.
Yamoah K; Zeigler-Johnson CM; Jeffers A; Malkowicz B; Spangler E; Park JY; Whittemore A; Rebbeck TR
BMC Cancer; 2016 Jul; 16():557. PubMed ID: 27473687
[TBL] [Abstract][Full Text] [Related]
19. Biochemical recurrence-free survival after robotic-assisted laparoscopic vs open radical prostatectomy for intermediate- and high-risk prostate cancer.
Ritch CR; You C; May AT; Herrell SD; Clark PE; Penson DF; Chang SS; Cookson MS; Smith JA; Barocas DA
Urology; 2014 Jun; 83(6):1309-15. PubMed ID: 24746665
[TBL] [Abstract][Full Text] [Related]
20. Impact of body mass index on outcomes of laparoscopic radical prostatectomy with long-term follow-up.
Gözen AS; Akin Y; Özden E; Ates M; Hruza M; Rassweiler J
Scand J Urol; 2015 Feb; 49(1):70-6. PubMed ID: 25130508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]